Ichiro Nakachi

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 626 citations

Interim Analysis, Oncology, Bevacizumab Versus Erlotinib +8

Comparison of Rapid Antigen Tests for COVID-19

Seiya Yamayoshi, Yuko Sakai‐Tagawa, Michiko Koga et al. · Viruses · 2020 · 221 citations · Full text

Diagnostic Virology, Infectious Virus Isolation, Viral Diagnostics +8

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito et al. · EClinicalMedicine · 2021 · 168 citations · Full text

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

Hideo Watanabe, Kenzo Soejima, Hiroyuki Yasuda et al. · Cancer Cell International · 2008 · 152 citations · Full text

Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease

Moumita Ghosh, York E. Miller, Ichiro Nakachi et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 119 citations · Full text